A nurse is reinforcing teaching with new parents about the provider's prescription for a serum bilirubin test. Which of the following statements should the nurse include in the explanation?

Neonatal jaundice assessment using serum bilirubin testing is performed to evaluate elevated bilirubin levels in newborns. This condition commonly occurs due to the immature hepatic system of the newborn, which is still developing its ability to conjugate and excrete bilirubin. Increased breakdown of fetal red blood cells after birth contributes to a higher bilirubin load. Understanding the physiologic basis of neonatal jaundice helps parents understand why monitoring is necessary even in otherwise healthy infants. Rationale: A. Having four bowel movements in the first day of life is not a risk factor for elevated bilirubin levels; in fact, frequent stooling helps eliminate bilirubin from the body through the gastrointestinal tract. Delayed stooling, not increased bowel movements, is associated with higher risk of jaundice. This does not explain the need for bilirubin testing. B. Congenital dermal melanocytosis is a benign pigmentation condition seen in newborns, especially those of certain ethnic backgrounds. It has no relationship to bilirubin metabolism or jaundice risk. Therefore, it does not justify the need for serum bilirubin testing. C. The newborn’s liver is physiologically immature and has a reduced ability to conjugate and eliminate bilirubin produced from normal red blood cell breakdown. This leads to accumulation of unconjugated bilirubin in the bloodstream, resulting in jaundice. This is the primary reason serum bilirubin levels are monitored in newborns. D. Breastfeeding is not an indication to stop or supplement with formula in most cases of neonatal jaundice. Although early breastfeeding jaundice can occur due to low intake, breastfeeding is generally encouraged. Routine formula supplementation is not recommended unless specifically indicated based on clinical assessment and bilirubin levels.